Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 15/20 | 0.49 |
| ▸ | PDE4A | P27815 | 11/20 | 0.49 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 11/20 | 0.49 |
| ▸ | PDE1C | Q14123 | 5/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL109922 | 1.00 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE1C | |
| SCHEMBL7418879 | 0.91 | PDE4B (0.51) | PDE4BPDE4APDE4CPDE4DPDE1C | |
| SCHEMBL7416606 | 0.90 | PDE4B (0.60) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7415505 | 0.90 | PDE4A (0.45) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7467100 | 0.90 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE1C | |
| SCHEMBL7466462 | 0.87 | PDE4A (0.51) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL6816264 | 0.86 | PDE4A (0.59) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL29008297 | 0.86 | PDE4B (0.48) | PDE4BPDE4APDE4CPDE4DPDE1C | |
| SCHEMBL931420 | 0.84 | PDE4B (0.53) | PDE4BPDE4APDE4CPDE4DPDE1C | |
| SCHEMBL5799817 | 0.84 | PDE4B (0.55) | PDE4BPDE4APDE4CPDE4DPDE1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916305-B | Multi-carrier medicament dispenser | 陆品公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-3436446-B1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-4185997-A1 | DOSE COUNTER ASSEMBLIES FOR MEDICAMENT DISPENSERS | Lupin Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| CN-116194114-A | Cathepsin inhibitors for preventing or treating viral infections | 葛兰素史密斯克莱知识产权发展有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-115916305-A | Multi-carrier medicament dispenser | 陆品公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-4126139-A1 | MULTI-CARRIER MEDICAMENT DISPENSERS | Lupin Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-4125919-A1 | CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL INFECTIONS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2023-02-08 | — | — | EP | disclosed |
| CN-110840847-B | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases | 沃泰克斯药物股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| WO-2022020506-A1 | DOSE COUNTER ASSEMBLIES FOR MEDICAMENT DISPENSERS | Lupin Inc. (US) | 2022-01-27 | — | — | WO | disclosed |